We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+2.79%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$33.6B
AUM Growth
-$258M
Cap. Flow
-$892M
Cap. Flow %
-2.66%
Top 10 Hldgs %
9.6%
Holding
1,511
New
98
Increased
472
Reduced
496
Closed
89
Avg Time Held
3.4 quarters
Top 10 Avg Time Held
2.1 quarters
Top 20 Avg Time Held
2.5 quarters

Top Buys

Rank Stock Value
1
NUS icon
Nu Skin
NUS
+$123M
2
DAN icon
Dana Inc
DAN
+$61.6M
3
BRCD
Brocade Communications Systems, Inc. NEW
BRCD
+$55.3M
4
CVEO icon
Civeo
CVEO
+$37.3M
5
PLUS icon
ePlus
PLUS
+$30M

Top Sells

Rank Stock Value
1
ZBRA icon
Zebra Technologies
ZBRA
+$107M
2
HP icon
Helmerich & Payne
HP
+$90.6M
3
OIS icon
Oil States International
OIS
+$59.7M
4
RS icon
Reliance Steel & Aluminium
RS
+$59.4M
5
MGLN
Magellan Health Services, Inc.
MGLN
+$44.4M

Sector Composition

Rank Sector Weight
1 Industrials 24.45%
2 Technology 18.1%
3 Consumer Discretionary 14.79%
4 Financials 9.92%
5 Materials 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
BNY icon
1376
Bank of New York Mellon
BNY
$96.9B
$51K ﹤0.01%
1,360
– –
2013 Q2
4 quarters
SHY icon
1377
iShares 1-3 Year Treasury Bond ETF
SHY
$26.8B
$50K ﹤0.01%
590
– –
2013 Q2
4 quarters
IMAX icon
1378
IMAX
IMAX
$2.84B
$48K ﹤0.01%
1,700
– –
2013 Q2
4 quarters
SQBG
1379
DELISTED
Sequential Brands Group, Inc.
SQBG
$48K ﹤0.01%
88
– –
2013 Q4
2 quarters
DGICA icon
1380
Donegal Group Class A
DGICA
$677M
$46K ﹤0.01%
3,000
– –
2013 Q3
3 quarters
EGIO icon
1381
DELISTED
Edgio, Inc. Common Stock
EGIO
$46K ﹤0.01%
+375
New +$35.6K
2014 Q2
0 quarters
CDI
1382
DELISTED
CDI Corp.
CDI
$46K ﹤0.01%
3,200
– –
2013 Q2
4 quarters
SLP icon
1383
DELISTED
Simulations Plus
SLP
$45K ﹤0.01%
+8,000
New +$48.1K
2014 Q2
0 quarters
STZ icon
1384
Constellation Brands
STZ
$21.4B
$44K ﹤0.01%
500
-1,800
-78% -$149K
2013 Q3
3 quarters
ICUI icon
1385
ICU Medical
ICUI
$4.1B
$43K ﹤0.01%
700
– –
2013 Q2
4 quarters
ALBO
1386
DELISTED
Albireo Pharma Inc
ALBO
$43K ﹤0.01%
670
– –
2013 Q4
2 quarters
OUTR
1387
DELISTED
OUTERWALL INC
OUTR
$42K ﹤0.01%
+700
New +$47.3K
2014 Q2
0 quarters
EPM icon
1388
Evolution Petroleum
EPM
$149M
$38K ﹤0.01%
3,500
– –
2013 Q3
3 quarters
LSAK icon
1389
Lesaka Technologies
LSAK
$422M
$38K ﹤0.01%
3,300
– –
2013 Q2
4 quarters
UNP icon
1390
Union Pacific
UNP
$167B
$38K ﹤0.01%
380
+60
+19% +$5.81K
2014 Q1
1 quarter
FRED
1391
DELISTED
Fred's Inc
FRED
$38K ﹤0.01%
2,500
– –
2013 Q2
4 quarters
DHX icon
1392
DHI Group
DHX
$208M
$37K ﹤0.01%
4,800
– –
2013 Q2
4 quarters
SAFT icon
1393
Safety Insurance
SAFT
$1.52B
$36K ﹤0.01%
700
– –
2013 Q2
4 quarters
PTN icon
1394
Palatin Technologies
PTN
$15.2M
$35K ﹤0.01%
28
– –
2013 Q2
4 quarters
SLB icon
1395
SLB Ltd
SLB
$72.4B
$34K ﹤0.01%
288
– –
2013 Q2
4 quarters
STRN icon
1396
DELISTED
SUTRON CORP
STRN
$34K ﹤0.01%
6,700
– –
2013 Q4
2 quarters
AXGN icon
1397
Axogen
AXGN
$2.18B
$33K ﹤0.01%
12,000
– –
2013 Q3
3 quarters
AFAM
1398
DELISTED
Almost Family Inc
AFAM
$33K ﹤0.01%
1,500
– –
2013 Q2
4 quarters
JAKK icon
1399
Jakks Pacific
JAKK
$317M
$31K ﹤0.01%
+400
New +$32.6K
2014 Q2
0 quarters
PRO icon
1400
DELISTED
PROS Holdings
PRO
$29K ﹤0.01%
+1,100
New +$28.6K
2014 Q2
0 quarters
54 55
56
57 58

Similar funds

JF
Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $12.5B AUM 306.52% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
LC
Loews Corp New York $12.5B AUM 4.69% 1-Year Est. Return
AIM
Adapt Investment Managers Geneva, Switzerland $12.6B AUM 11.86% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $12.6B AUM 31.26% 1-Year Est. Return
BAMF
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $12.6B AUM 41.69% 1-Year Est. Return

Royce & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Royce & Associates held 1,511 positions worth $33.6B, down 0.76% from $33.9B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Royce & Associates's Q2 2014 filing shows 98 new, 472 increased, 496 reduced and 89 closed positions. Its largest new stake was Civeo: 124,691 shares worth $37.5M. The largest sale was Zebra Technologies, an estimated $107M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Royce & Associates's largest Q2 2014 buy was Civeo: 124,691 shares worth $37.5M.
  • Royce & Associates added most to Nu Skin in Q2 2014, an estimated $123M increase.
  • Royce & Associates's biggest Q2 2014 reduction was Zebra Technologies, cutting an estimated $107M.
  • Royce & Associates fully exited Entegris in Q2 2014, selling an estimated $35.5M.
  • Royce & Associates's ten largest holdings make up 9.6% of its $33.6B portfolio in Q2 2014.
  • Royce & Associates opened 98 new positions and closed 89 in Q2 2014.
  • Royce & Associates's portfolio value fell 0.76% quarter-over-quarter to $33.6B.

Based on Royce & Associates's 13F filing for Q2 2014, filed 11 Aug 2014.